Drug: CELLCEPT Injury: Interstitial lung disease Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
88354513 | CELLCEPT | Interstitial lung disease | SANDOZ | 42.00 YR | F | 0 | 20160810 | CN |
125267031 | CELLCEPT | Interstitial lung disease | ASTELLAS | 65.59 YR | M | 0 | 20160705 | FR |
125286221 | CELLCEPT | Interstitial lung disease | NOVO NORDISK | 71.00 YR | M | 0 | 20160705 | FR |
125289401 | CELLCEPT | Interstitial lung disease | AVENTIS | 71.00 YR | M | 0 | 20160705 | FR |
125498941 | CELLCEPT | Interstitial lung disease | ASTRAZENECA | 862.00 MON | M | 0 | 20160712 | FR |
127635891 | CELLCEPT | Interstitial lung disease | AVENTIS | 35.00 YR | F | 0 | 20160920 | FR |
127711792 | CELLCEPT | Interstitial lung disease | PFIZER | 35.00 YR | F | 0 | 20160927 | FR |
127847881 | CELLCEPT | Interstitial lung disease | JANSSEN | 0.00 | F | 0 | 20160927 | FR |
127868721 | CELLCEPT | Interstitial lung disease | ALLERGAN | 35.00 YR | F | 0 | 20160927 | FR |
Total Records: 9 Number of Pages: 1